It is quite easy to be drowned in the rising floodwaters of hematology and medical oncology, especially when you start training.
June 2016
As the end of my hematology/oncology fellowship draws near, I am reminded every day that oncology is not about winning or losing.
Through this eventful journey, I have experienced stark contrasts.
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
3
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
4
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
5